Market Overview:
The global intravenous stopcock market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising demand for homecare services, and technological advancements in intravenous stopcocks. Based on type, the global intravenous stopcock market is segmented into three-way stop cock and others. The three-way stop cock segment is expected to account for the majority share of the global market in 2018 owing to its widespread use across hospitals & clinics, homecare, and ambulatory care centers. Based on application, the global intravenous stopcock market is segmented into hospitals & clinics, homecare services, and ambulatory care centers. Hospitals & clinics are expected to account for the majority share of this market in 2018 due to rising demand for healthcare services worldwide.
Product Definition:
Intravenous Stopcock is a device used to stop the flow of liquid medicine or other fluid substances from entering or leaving a vein. It is also known as an intravenous clamp.
Three Way Stop Cock:
Three way stopcock, also known as T-piece or tripper, is a device used to drain the bladder. It consists of an attached hose and a valve that can be operated by hand or automatically. The product has three functions: it can be used to empty the bladder; it can act as a male catheter when connected to a female catheter; and it acts as an oral syringe when attached to an IV tube.
Others:
Others include any other medical device or equipment that is used in the process of intravenous (IV) stopcock. The IV stopcock is a small tube attached to an IV set which helps in opening and closing the flow of fluid from a patient’s vein into a container for administration to another patient. It works by drawing blood from one patient and giving it to another.
Application Insights:
Based on the application, the global intravenous stopcock market is segmented into hospitals and clinics, homecare settings, and ambulatory care centers. The hospitals and clinics segment dominated the market in 2017 owing to a large number of IV access procedures performed in these facilities. In addition, a high prevalence of chronic diseases such as cancer that require parenteral nutrition is expected to drive demand for IV nutritional support over the forecast period.
The homecare setting was one of the prominent segments accounting for a significant share in 2017 due to an increasing number of patients suffering from various chronic conditions requiring long term care at home who are opting for this type of medical equipment. Moreover, an increase in healthcare expenditure by government authorities as well as private organizations has resulted in increased spending on advanced healthcare services which has further driven growth over recent years.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high awareness among people about advanced technologies, and increasing number of product launches are some factors driving the market growth in this region. In addition, rising incidence of central line-associated infections is also expected to drive the demand for intravenous (IV) stopcocks during the forecast period.
Asia Pacific is anticipated to be one of fastest growing regions owing to improving healthcare facilities and an increase in government initiatives for promoting quality medical care services especially at home setting up ambulatory care centers by hospitals & clinics as a result better patient outcomes will boost revenue generation over the forecast period.
Europe was valued at USD X billion due to its large geriatric population base that requires continuous monitoring.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits of people. Intravenous stopcocks are used to administer medication and other treatments to patients suffering from chronic diseases, which is expected to drive the market growth in the coming years.
- Technological advancements: The intravenous stopcock market is witnessing rapid technological advancements, with new products being launched regularly in order to meet the needs of healthcare professionals and patients alike. This is likely to fuel market growth in the near future.
- Rising demand for minimally invasive procedures: Minimally invasive procedures are becoming increasingly popular due to their many benefits over traditional surgical procedures, such as shorter hospital stays and reduced pain levels post-surgery. Intravenous stopcocks are widely used in minimally invasive procedures, thereby propelling market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intravenous Stopcock Market Research Report
By Type
Three Way Stop Cock, Others
By Application
Hospitals & Clinics, Homecare, Ambulatory Care Center
By Companies
Smiths Medical, Bound Tree Medical, Mediprim, Fresenius Kabi, Neotec Medical Industries, ICU Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Intravenous Stopcock Market Report Segments:
The global Intravenous Stopcock market is segmented on the basis of:
Types
Three Way Stop Cock, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinics, Homecare, Ambulatory Care Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smiths Medical
- Bound Tree Medical
- Mediprim
- Fresenius Kabi
- Neotec Medical Industries
- ICU Medical
Highlights of The Intravenous Stopcock Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Three Way Stop Cock
- Others
- By Application:
- Hospitals & Clinics
- Homecare
- Ambulatory Care Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intravenous Stopcock Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intravenous stopcock is a medical device that allows physicians to administer fluids and other medications directly into the veins of patients.
Some of the major players in the intravenous stopcock market are Smiths Medical, Bound Tree Medical, Mediprim, Fresenius Kabi, Neotec Medical Industries, ICU Medical.
The intravenous stopcock market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Intravenous Stopcock Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Intravenous Stopcock Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Intravenous Stopcock Market - Supply Chain
4.5. Global Intravenous Stopcock Market Forecast
4.5.1. Intravenous Stopcock Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Intravenous Stopcock Market Size (000 Units) and Y-o-Y Growth
4.5.3. Intravenous Stopcock Market Absolute $ Opportunity
5. Global Intravenous Stopcock Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Intravenous Stopcock Market Size and Volume Forecast by Type
5.3.1. Three Way Stop Cock
5.3.2. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Intravenous Stopcock Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Intravenous Stopcock Market Size and Volume Forecast by Application
6.3.1. Hospitals & Clinics
6.3.2. Homecare
6.3.3. Ambulatory Care Center
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Intravenous Stopcock Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Intravenous Stopcock Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Intravenous Stopcock Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Intravenous Stopcock Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Intravenous Stopcock Demand Share Forecast, 2019-2026
9. North America Intravenous Stopcock Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Intravenous Stopcock Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Intravenous Stopcock Market Size and Volume Forecast by Application
9.4.1. Hospitals & Clinics
9.4.2. Homecare
9.4.3. Ambulatory Care Center
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Intravenous Stopcock Market Size and Volume Forecast by Type
9.7.1. Three Way Stop Cock
9.7.2. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Intravenous Stopcock Demand Share Forecast, 2019-2026
10. Latin America Intravenous Stopcock Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Intravenous Stopcock Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Intravenous Stopcock Market Size and Volume Forecast by Application
10.4.1. Hospitals & Clinics
10.4.2. Homecare
10.4.3. Ambulatory Care Center
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Intravenous Stopcock Market Size and Volume Forecast by Type
10.7.1. Three Way Stop Cock
10.7.2. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Intravenous Stopcock Demand Share Forecast, 2019-2026
11. Europe Intravenous Stopcock Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Intravenous Stopcock Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Intravenous Stopcock Market Size and Volume Forecast by Application
11.4.1. Hospitals & Clinics
11.4.2. Homecare
11.4.3. Ambulatory Care Center
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Intravenous Stopcock Market Size and Volume Forecast by Type
11.7.1. Three Way Stop Cock
11.7.2. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Intravenous Stopcock Demand Share, 2019-2026
12. Asia Pacific Intravenous Stopcock Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Intravenous Stopcock Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Intravenous Stopcock Market Size and Volume Forecast by Application
12.4.1. Hospitals & Clinics
12.4.2. Homecare
12.4.3. Ambulatory Care Center
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Intravenous Stopcock Market Size and Volume Forecast by Type
12.7.1. Three Way Stop Cock
12.7.2. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Intravenous Stopcock Demand Share, 2019-2026
13. Middle East & Africa Intravenous Stopcock Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Intravenous Stopcock Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Intravenous Stopcock Market Size and Volume Forecast by Application
13.4.1. Hospitals & Clinics
13.4.2. Homecare
13.4.3. Ambulatory Care Center
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Intravenous Stopcock Market Size and Volume Forecast by Type
13.7.1. Three Way Stop Cock
13.7.2. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Intravenous Stopcock Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Intravenous Stopcock Market: Market Share Analysis
14.2. Intravenous Stopcock Distributors and Customers
14.3. Intravenous Stopcock Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Smiths Medical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bound Tree Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Mediprim
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fresenius Kabi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Neotec Medical Industries
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ICU Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook